Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
주식 순위
#2198
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
주가
$3.40
시가총액
$9.07B
변동 (1일)
-1.61%
변동 (1년)
-16.08%
국가
CN
거래 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
카테고리
Healthcare
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)의 매출
Oct 2026 기준 매출 TTM: 0
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.의 수익 기록 (2001 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2025 | $5.93B | 5.44% |
| 2024 | $5.63B | -3.80% |
| 2023 | $5.85B | -8.21% |
| 2022 | $6.37B | 3.81% |
| 2021 | $6.14B | 32.30% |
| 2020 | $4.64B | 13.01% |
| 2019 | $4.11B | 13.32% |
| 2018 | $3.62B | 27.17% |
| 2017 | $2.85B | 35.20% |
| 2016 | $2.11B | 8.52% |
| 2015 | $1.94B | 0.01% |
| 2014 | $1.94B | 17.81% |
| 2013 | $1.65B | 39.99% |
| 2012 | $1.18B | 14.43% |
| 2011 | $1.03B | 49.06% |
| 2010 | $690.17M | 22.38% |
| 2009 | $563.96M | 1.99% |
| 2008 | $552.97M | 9.32% |
| 2007 | $505.81M | -3.27% |
| 2006 | $522.92M | 41.24% |
| 2005 | $370.24M | 27.18% |
| 2004 | $291.11M | 11.82% |
| 2003 | $260.35M | 108.87% |
| 2002 | $124.64M | 41.71% |
| 2001 | $87.96M | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | - |
IN
|
